- What does SHSCX invest in?
- This fund commits a minimum of 80% of its total capital to equity investments, primarily common stocks, issued by companies active in the health sciences and related industries. This scope includes, but is not limited to, businesses specializing in medical equipment and supplies, healthcare provision and services, biotechnology, and pharmaceuticals. A substantial portion of its portfolio, exceeding 25% of its assets, will be concentrated within these health sciences or associated sectors. Furthermore, the fund has the discretion to invest in companies based in non-U.S. countries.
- What is the expense ratio of SHSCX?
- BlackRock Health Sciences Opportunities Portfolio (SHSCX) charges an expense ratio of 1.90%. This is the annual fee deducted from fund assets to cover management and operations.
- How big is SHSCX?
- BlackRock Health Sciences Opportunities Portfolio (SHSCX) is one share class of a fund that manages $6.44B across all of its share classes (BHSRX, SHISX, SHSAX, SHSKX, SHSSX report the same total). Our data does not carry the assets of this share class alone. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation.
- Is SHSCX actively managed or an index fund?
- SHSCX is actively managed: the manager selects holdings rather than tracking an index. Active funds typically charge higher expense ratios than index funds (SHSCX's is 1.90%) in exchange for the discretion to over- or under-weight positions.
- When was SHSCX launched?
- BlackRock Health Sciences Opportunities Portfolio (SHSCX) launched in October 2000 and is managed by BlackRock.
- How has SHSCX performed?
- SHSCX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.
